Sunday, March 9, 2025

Healthcare

Investing in Hope: Why Cancer Therapy is the Sector You Can’t Ignore

All investors should definitely have quality investment in the Cancer therapy sector either directly or as a proxy. Very simply. The goal of cancer treatment...

Breakthrough in Cancer Treatment: Aprea’s ATRN-119 Trial Shows Promise with Latest Milestone

Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea," or the "Company"), a clinical-stage precision oncology company, has achieved a significant milestone. The first patient has been...

Top 6 Performant Biotech Stocks to Invest in

The biotechnology sector continues to thrive with innovative companies making significant strides in medical technology and pharmaceuticals. Below is an in-depth look at six...

RenovoRx’s TAMP Therapy: A Revolutionary Approach to Combating Pancreatic Cancer

Renovo (RenovoRx Nasdaq: RNXT), is a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform. Oncologist is an international peer-reviewed...

Should You Invest in RenovoRX Now?

RenovoRx (RNXT) is a life sciences company at the forefront of developing targeted oncology therapies aimed at addressing unmet medical needs in cancer treatment....

Popular

Subscribe